Overview of cefixime use in community-acquired infections.
Hamilton-Miller
J M
JM
Department of Medical Microbiology, Royal Free and University College Medical School, London, UK. j.hamilton-miller@rfhsm.ac.uk
D020682:Cefixime / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D002511:Cephalosporins / Q000494:pharmacology / Q000627:therapeutic use* / Q000652:urine; D017714:Community-Acquired Infections / Q000188:drug therapy* / Q000382:microbiology; D004927:Escherichia coli Infections / Q000188:drug therapy; D005260:Female; D006192:Haemophilus Infections / Q000188:drug therapy; D006801:Humans; D008297:Male; D016870:Neisseriaceae Infections / Q000188:drug therapy; D010349:Patient Compliance; D012141:Respiratory Tract Infections / Q000188:drug therapy / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy; D013290:Streptococcal Infections / Q000188:drug therapy; D014552:Urinary Tract Infections / Q000188:drug therapy / Q000382:microbiology
D002511:Cephalosporins; D020682:Cefixime